Latest in Kroger’s stock jumps 6% after profit beat though CEO says more affluent customer now also wary on spending
Sort by
10,931 items
-
Budget to benefit less affluent shoppers despite hit to business, says Primark owner
ABF warns changes to national insurance and wages will cost it tens of millions but remains optimisticBusiness - Financial Times - November 5 -
CVS cuts outlook yet again — while swapping out CEO for a company veteran
“The shift in management is not surprising as the company looks to level set its operations and strategically position itself for future growth,” analyst said.Business - MarketWatch - October 18 -
CVS Health CEO Karen Lynch steps down after 19% stock plunge
CVS Health CEO Karen Lynch has stepped down and is being replaced by David Joyner amid struggles with rising costs.Top stories - CBS News - October 18 -
Peloton’s stock soars 30% after company names Apple Fitness+ co-founder as new CEO
Peloton announced the appointment of Peter Stern as new CEO effective Jan. 1. Stern is the co-founder of Apple Fitness+ and has done stints at Ford Motor Co. and Time Warner Cable.Business - MarketWatch - October 31 -
Wall Street is entering its best 6 months of the year. Why the stock-market rally has more room to run.
The U.S. stock market is about to enter historically its best six months of the year, after defying the popular Wall Street adage to “sell in May and go away” with strong gains.Business - MarketWatch - October 30 -
Big Tech stocks rally, as tech now drives S&P 500 more than on Election Day 2016
Big Tech stocks rallied Tuesday as Americans cast their vote for the next U.S. president, fueling the S&P 500’s sharp gain.Business - MarketWatch - 6 days ago -
Royal Caribbean CEO: Americans are ‘wealthier than ever’ and love to travel
Royal Caribbean’s stock pulls back from a record after revenue, profit outlook for the current quarter disappoint.Business - MarketWatch - October 29 -
Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance
Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.Business - CNBC - October 30